Immunotherapy: a potential adjunctive treatment for fungal infection

scientific article

Immunotherapy: a potential adjunctive treatment for fungal infection is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1097/QCO.0000000000000105
P698PubMed publication ID25304393

P50authorMihai NeteaQ24517868
Bart Jan KullbergQ62560089
Frank van de VeerdonkQ92689750
P433issue6
P921main subjectimmunotherapyQ1427096
P1104number of pages6
P304page(s)511-516
P577publication date2014-12-01
P1433published inCurrent Opinion in Infectious DiseasesQ15724406
P1476titleImmunotherapy: a potential adjunctive treatment for fungal infection
P478volume27

Reverse relations

cites work (P2860)
Q54205003Effect of ArtinM on Human Blood Cells During Infection With Paracoccidioides brasiliensis.
Q30235457Intensive care medicine research agenda on invasive fungal infection in critically ill patients
Q56040929Invasive candidiasis
Q47334511Modulating Host Signaling Pathways to Promote Resistance to Infection by Candida albicans
Q59708823Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
Q49679946Patient Susceptibility to Candidiasis-A Potential for Adjunctive Immunotherapy
Q38692399Promising immunotherapy against fungal diseases
Q39742832Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor
Q93014010Thioredoxin Reductase 1 Is a Highly Immunogenic Cell Surface Antigen in Paracoccidioides spp., Candida albicans, and Cryptococcus neoformans

Search more.